Abstract:Subpopulations of somatosensory neurons are characterized by functional properties and expression of receptor proteins and surface markers. CGRP expression and IB4-binding are commonly used to define peptidergic and non-peptidergic subpopulations. TRPA1 is a polymodal, plasma membrane ion channel that contributes to mechanical and cold hypersensitivity during tissue injury, making it a key target for pain therapeutics. Some studies have shown that TRPA1 is predominantly expressed by peptidergic sensory neurons, but others indicate that TRPA1 is expressed extensively within non-peptidergic, IB4-binding neurons. We used FURA-2 calcium imaging to define the functional distribution of TRPA1 among peptidergic and non-peptidergic adult mouse (C57BL/6J) DRG neurons. Approximately 80% of all small-diameter (<27 µm) neurons from lumbar 1-6 DRGs that responded to TRPA1 agonists allyl isothiocyanate (AITC; 79%) or cinnamaldehyde (84%) were IB4-positive. Retrograde labeling via plantar hind paw injection of WGA-Alexafluor594 showed similarly that most (81%) cutaneous neurons responding to TRPA1 agonists were IB4-positive. Additionally, we cultured DRG neurons from a novel CGRP-GFP mouse where GFP expression is driven by the CGRPα promoter, enabling identification of CGRP-expressing live neurons. Interestingly, 78% of TRPA1-responsive neurons were CGRP-negative. Co-labeling with IB4 revealed that the majority (66%) of TRPA1 agonist responders were IB4-positive but CGRP-negative. Among TRPA1-null DRGs, few small neurons (2-4%) responded to either TRPA1 agonist, indicating that both cinnamaldehyde and AITC specifically target TRPA1. Additionally, few large neurons (≥27 µm diameter) responded to AITC (6%) or cinnamaldehyde (4%), confirming that most large-diameter somata lack functional TRPA1. Comparison of mouse and rat DRGs showed that the majority of TRPA1-responsive neurons in both species were IB4-positive. Together, these data demonstrate that TRPA1 is functionally expressed primarily in the IB4-positive, CGRP-negative subpopulation of small lumbar DRG neurons from rodents. Thus, IB4 binding is a better indicator than neuropeptides for TRPA1 expression.

Identification of a Splice Variant of Mouse TRPA1 That Regulates TRPA1 Activity

Identification Of A Splice Variant Of Mouse Trpa1 That Regulates Trpa1 Activity (Vol 4, 2399, 2013)

TRPV1 Gain-of-function Mutation Impairs Pain and Itch Sensations in Mice

Molecular Determinants of Species-Specific Activation or Blockade of TRPA1 Channels.

Annexin A2 Regulates TRPA1-Dependent Nociception

Slack Potassium Channels Modulate TRPA1-Mediated Nociception in Sensory Neurons

Inhibitory Modulation Of Distal C-Terminal On Protein Kinase C-Dependent Phospho-Regulation Of Rat Trpv1 Receptors

Molecular mechanism of hyperactivation conferred by a truncation of TRPA1

CYP1B1-derived epoxides modulate the TRPA1 channel in chronic pain

Pro-inflammatory mediators sensitise Transient Receptor Potential Melastatin 3 cation channel (TRPM3) signalling in mouse sensory neurons

Molecular basis of TRPA1 regulation in nociceptive neurons. A review

Distinctive Drug Binding Sites and Gating Mechanisms of the Nociceptive Ion Channel TRPA1

Trpa1: the Species Difference

The mechanism of Annexin A1 to modulate TRPV1 and nociception in dorsal root ganglion neurons

Involvement of interaction of Cav3.2 and nociceptive TRPA1 in pathological pain transmission

Identification of an N-terminal TRPC2 splice variant which inhibits calcium influx.

TRPV1 SUMOylation regulates nociceptive signaling in models of inflammatory pain

TRPA1 is functionally expressed primarily by IB4-binding, non-peptidergic mouse and rat sensory neurons

TRPC3/6 Channels Mediate Mechanical Pain Hypersensitivity via Enhancement of Nociceptor Excitability and of Spinal Synaptic Transmission

Site-specific contacts enable distinct modes of TRPV1 regulation by the potassium channel Kvβ1 subunit

TRPV1 is involved in abdominal hyperalgesia in a mouse model of lipopolysaccharide-induced peritonitis and influences the immune response via peripheral noradrenergic neurons